{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T05:59:30Z","timestamp":1789365570662,"version":"build-2803163510"},"reference-count":37,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2006,9,1]],"date-time":"2006-09-01T00:00:00Z","timestamp":1157068800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Injury"],"published-print":{"date-parts":[[2006,9]]},"DOI":"10.1016\/j.injury.2006.02.007","type":"journal-article","created":{"date-parts":[[2006,4,19]],"date-time":"2006-04-19T17:42:33Z","timestamp":1145468553000},"page":"818-826","source":"Crossref","is-referenced-by-count":22,"title":["Early experience with linezolid for infections in orthopaedics"],"prefix":"10.1016","volume":"37","author":[{"given":"P.J.","family":"Harwood","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Talbot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Dimoutsos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Sunderland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Shaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.H.","family":"Wilcox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.V.","family":"Giannoudis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.injury.2006.02.007_bib2","first-page":"99","article-title":"MRSA with intermediate resistance to teicoplanin","volume":"10","author":"Anonymous","year":"2000","journal-title":"Commun Dis Report Weekly"},{"key":"10.1016\/j.injury.2006.02.007_bib3","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1093\/jac\/46.4.639-a","article-title":"Twenty months of screening for glycopeptide-intermediate Staphylococcus aureus","volume":"46","author":"Aucken","year":"2000","journal-title":"J Antimicrob Chemother"},{"issue":"2","key":"10.1016\/j.injury.2006.02.007_bib4","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1086\/345744","article-title":"Linezolid for the treatment of multidrug-resistant, gram-positive infections: experience from a compassionate-use program","volume":"36","author":"Birmingham","year":"2003","journal-title":"Clin Infect Dis"},{"issue":"Suppl 4","key":"10.1016\/j.injury.2006.02.007_bib5","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1046\/j.1469-0691.2001.00061.x","article-title":"Linezolid: pharmacokinetic characteristics and clinical studies","volume":"7","author":"Bouza","year":"2001","journal-title":"Clin Microbiol Infect"},{"issue":"2","key":"10.1016\/j.injury.2006.02.007_bib6","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ijantimicag.2003.11.003","article-title":"Oxazolidinones: activity, mode of action, and mechanism of resistance","volume":"23","author":"Bozdogan","year":"2004","journal-title":"Int J Antimicrob Agents"},{"issue":"4","key":"10.1016\/j.injury.2006.02.007_bib7","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1097\/01.sap.0000106888.60963.18","article-title":"Clinical experience with linezolid in conjunction with wound coverage techniques for skin and soft-tissue infections and post-operative osteomyelitis","volume":"52","author":"Broder","year":"2004","journal-title":"Ann Plast Surg"},{"key":"10.1016\/j.injury.2006.02.007_bib8","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1086\/314035","article-title":"Analysis of 42 cases of septicemia caused by an epidemic strain of methicillin-resistant Staphylococcus aureus: evidence of resistance to vancomycin","volume":"31","author":"Burnie","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.injury.2006.02.007_bib9","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1086\/381093","article-title":"Clinical fearures associated with bacteraemia due to heterogeneous vancomycin-intermediate Staphylococcus aureus","volume":"38","author":"Charles","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.injury.2006.02.007_bib10","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1128\/AAC.47.8.2655-2658.2003","article-title":"Efficacy of linezolid plus rifampin in an experimental model of methicillin-susceptible Staphylococcus aureus endocarditis","volume":"47","author":"Dailey","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1016\/j.injury.2006.02.007_bib11","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1086\/380457","article-title":"Antimicrobial resistance trends and outbreak frequency in United States hospitals","volume":"38","author":"Diekema","year":"2004","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.injury.2006.02.007_bib12","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1128\/AAC.47.1.418-420.2003","article-title":"In vitro bactericidal activities of linezolid in combination with vancomycin, gentamicin, ciprofloxacin, fusidic acid, and rifampin against Staphylococcus aureus","volume":"47","author":"Grohs","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.injury.2006.02.007_bib13","doi-asserted-by":"crossref","first-page":"2985","DOI":"10.1128\/JCM.38.8.2985-2988.2000","article-title":"Outbreak of methicillin-resistant Staphylococcus aureus with reduced susceptibility to glycopeptides in a Parisian hospital","volume":"38","author":"Guerin","year":"2000","journal-title":"J Clin Microbiol"},{"issue":"5","key":"10.1016\/j.injury.2006.02.007_bib14","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1517\/14740338.3.5.405","article-title":"The safety and efficacy of linezolid in orthopaedic practice for the treatment of infection due to antibiotic resistant organisms","volume":"3","author":"Harwood","year":"2004","journal-title":"Expert Opin Drug Saf"},{"issue":"6","key":"10.1016\/j.injury.2006.02.007_bib15","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1093\/jac\/46.6.931","article-title":"Susceptibility of gram-positive cocci from 25 UK hospitals to antimicrobial agents including linezolid. The Linezolid Study Group","volume":"46","author":"Henwood","year":"2000","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.injury.2006.02.007_bib16","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/S0140-6736(04)16803-7","article-title":"hGISA: seek and ye shall find","volume":"364","author":"Howe","year":"2004","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.injury.2006.02.007_bib17","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/S0736-0266(03)00103-7","article-title":"Cryopreservation of tissue engineered constructs for bone","volume":"21","author":"Kofron","year":"2003","journal-title":"J Orthop Res"},{"issue":"12","key":"10.1016\/j.injury.2006.02.007_bib18","doi-asserted-by":"crossref","first-page":"3964","DOI":"10.1128\/AAC.47.12.3964-3966.2003","article-title":"Linezolid penetration into bone and joint tissues infected with methicillin-resistant staphylococci","volume":"47","author":"Kutscha-Lissberg","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1016\/j.injury.2006.02.007_bib19","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1086\/380449","article-title":"Treating foot infections in diabetic patients: a randomised, multicenter, open-label trial of linezolid versus ampicillin-sulbactam\/amoxicillin-clavulanate","volume":"38","author":"Lipsky","year":"2004","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.injury.2006.02.007_bib20","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1093\/jac\/dkf066","article-title":"Penetration of linezolid into bone, fat, muscle and haematoma of patients undergoing routine hip replacement","volume":"50","author":"Lovering","year":"2002","journal-title":"J Antimicrob Chemother"},{"issue":"Suppl 2","key":"10.1016\/j.injury.2006.02.007_bib21","first-page":"ii17","article-title":"Pharmacokinetic and pharmacodynamic profile of linezolid in healthy volunteers and patients with Gram-positive infections","volume":"51","author":"MacGowan","year":"2003","journal-title":"J Antimicrob Chemother"},{"issue":"6","key":"10.1016\/j.injury.2006.02.007_bib22","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1179\/joc.2000.12.6.459","article-title":"Evolution of antibiotic resistance in gram-positive pathogens","volume":"12","author":"Marchese","year":"2000","journal-title":"J Chemother"},{"key":"10.1016\/j.injury.2006.02.007_bib23","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1086\/423841","article-title":"Antimicrobial resistance to linezolid","volume":"39","author":"Meka","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.injury.2006.02.007_bib24","series-title":"Proceedings of the 44th interscience conference on antimicrobial agents and chemotherapy, Americal society for microbiology","article-title":"Suppression of linezolid resistance in Staphylococcus aureus using drug combinations","author":"Miller","year":"2004"},{"issue":"6","key":"10.1016\/j.injury.2006.02.007_bib25","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1093\/jac\/dkf215","article-title":"The efficacy and safety of linezolid as treatment for Staphylococcus aureus infections in compassionate use patients who are intolerant of, or who have failed to respond to vancomycin","volume":"50","author":"Moise","year":"2002","journal-title":"J Antimicrob Chemother"},{"issue":"2","key":"10.1016\/j.injury.2006.02.007_bib26","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1093\/jac\/dkg061","article-title":"Cost-minimization analysis and audit of antibiotic management of bone and joint infections with ambulatory teicoplanin, in-patient care or outpatient oral linezolid therapy","volume":"51","author":"Nathwani","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.injury.2006.02.007_bib27","series-title":"Surveillance of surgical site infection in English hospitals 1997\u20132001","author":"NINSS","year":"2002"},{"issue":"2","key":"10.1016\/j.injury.2006.02.007_bib28","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1086\/647776","article-title":"Difference in incidence and transmission mode of methicillin-resistant Staphylococcus aureus among surgery, orthopedics, and pediatrics wards: a prospective study at a university hospital","volume":"19","author":"Nishi","year":"1998","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.injury.2006.02.007_bib29","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1086\/646765","article-title":"Trends in antimicrobial utilization at a tertiary teaching hospital during a 15-year period (1978\u20131992)","volume":"14","author":"Pallares","year":"1993","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"5","key":"10.1016\/j.injury.2006.02.007_bib30","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1093\/jac\/dkf207","article-title":"Linezolid penetration into osteo-articular tissues","volume":"50","author":"Rana","year":"2002","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.injury.2006.02.007_bib31","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/01.blo.0000144860.11193.5e","article-title":"Successful treatment of chronic bone and joint infections with oral linezolid","volume":"427","author":"Rao","year":"2004","journal-title":"Clin Orthop Relat Res"},{"key":"10.1016\/j.injury.2006.02.007_bib32","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1136\/bmj.320.7229.213","article-title":"Bacteraemia and antibiotic resistance of its pathogens reported in England and Wales between 1990 and 1998: trend analysis","volume":"320","author":"Reacher","year":"2000","journal-title":"Brit Med J"},{"issue":"1","key":"10.1016\/j.injury.2006.02.007_bib33","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1179\/joc.2001.13.Supplement-2.89","article-title":"The role of methicillin-resistant Staphylococcus aureus in orthopaedic implant surgery","volume":"13SpecNo1","author":"Sanderson","year":"2001","journal-title":"J Chemother"},{"key":"10.1016\/j.injury.2006.02.007_bib34","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1056\/NEJM199902183400701","article-title":"Emergence of vancomycin resistance in Staphylococcus aureus. Glycopeptide-Intermediate Staphylococcus aureus Working Group","volume":"340","author":"Smith","year":"1999","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.injury.2006.02.007_bib35","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1086\/340353","article-title":"Linezolid versus vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections","volume":"34","author":"Stevens","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.injury.2006.02.007_bib36","series-title":"Proceedings of the 35th interscience conference on antimicrobial agents and chemotherapy","article-title":"A comparative study of vancomycin and lactams in the treatment of staphylococcal bacteraemia in hemodialysis patients","author":"Tam","year":"1995"},{"issue":"Suppl 2","key":"10.1016\/j.injury.2006.02.007_bib37","first-page":"ii27","article-title":"Efficacy of linezolid versus comparator therapies in gram-positive infections","volume":"51","author":"Wilcox","year":"2003","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"10.1016\/j.injury.2006.02.007_bib38","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1089\/109629601750185334","article-title":"Clinical trial results with linezolid, an oxazolidinone, in the treatment of soft tissue and post-operative gram-positive infections","volume":"2","author":"Wilson","year":"2001","journal-title":"Surg Infect (Larchmt)"}],"container-title":["Injury"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0020138306000726?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0020138306000726?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,13]],"date-time":"2020-04-13T23:36:33Z","timestamp":1586820993000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0020138306000726"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,9]]},"references-count":37,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2006,9]]}},"alternative-id":["S0020138306000726"],"URL":"https:\/\/doi.org\/10.1016\/j.injury.2006.02.007","relation":{},"ISSN":["0020-1383"],"issn-type":[{"value":"0020-1383","type":"print"}],"subject":[],"published":{"date-parts":[[2006,9]]}}}